Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

DDX41 mutation in Patients with Idiopathic Cytopenia of Undetermined Significance, Myelodysplastic Syndrome, and Acute Myeloid Leukemia

Eun-Ji Choi, MD, Young-Uk Cho, MD, Seongsoo Jang, Chan-jeoung Park, Han-Seung Park, MD, Jung-Hee Lee, MD PhD, Kyoo Hyung Lee, MD PhD, Eun-Hye Hur, PhD, Nayoung Kim, PhD, Hee Jeong Ouk, MD, Je-Hwan Lee, MD PhD

Blood (2019) 134 (Supplement_1): 3002.

https://doi.org/10.1182/blood-2019-129906

Published: 2019

Journal Articles

Mutational Characteristics and Changing Pattern from Idiopathic Cytopenia of Undetermined Significance to High-Risk Myelodysplastic Syndrome Stratified By IPSS-R

Eun-Ji Choi, MD, Young-Uk Cho, MD, Seongsoo Jang, Chan-jeoung Park, Han-Seung Park, MD, Jung-Hee Lee, MD PhD, Kyoo-Hyung Lee, MD PhD, Eun-Hye Hur, PhD, Nayoung Kim, PhD, Hee Jeong Ouk, MD, Je-Hwan Lee, MD PhD

Blood (2019) 134 (Supplement_1): 3009.

https://doi.org/10.1182/blood-2019-125236

Published: 2019

Journal Articles

Clinical Implications of Copy Number Variant Detection from Panel-Based Next-Generation Sequencing Data in Myelodysplastic Syndrome

Je-Hwan Lee, MD PhD, Yoo-Jin Kim, MD PhD, Seung-Hyun Jung, Eun-Hye Hur, Eun-Ji Choi, MD, Kyoo Hyung Lee, MD PhD, Seon-Hee Yim, Hye-Jung Kim, Yong-Rim Kwon, Young-Woo Jeon, MD PhD, Sug Hyung Lee, Yeun-Jun Chung

Blood (2019) 134 (Supplement_1): 4264.

https://doi.org/10.1182/blood-2019-131570

Published: 2019

Journal Articles

Decitabine Versus Intensive Chemotherapy for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Eun-Ji Choi, MD, Je-Hwan Lee, MD PhD, Han-Seung Park, MD, Jung-Hee Lee, MD PhD, Miee Seol, Young-Shin Lee, Young-Ah Kang, Mijin Jeon, Ji Min Woo, Kyoo Hyung Lee, MD PhD

Blood (2018) 132 (Supplement 1): 2713.

https://doi.org/10.1182/blood-2018-99-116102

Published: 2018

Journal Articles

Multicenter, Open-Label, 3-Arm Study of Gilteritinib, Gilteritinib Plus Azacitidine, or Azacitidine Alone in Newly Diagnosed FLT 3 Mutated ( FLT3 mut+ ) Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Induction Chemotherapy: Findings from the Safety Cohort

Jordi Esteve, MD PhD, Rik Schots, Teresa Bernal Del Castillo, MD PhD, Je-Hwan Lee, MD PhD, Eunice S. Wang, MD, Shira Dinner, MD, Mark D. Minden, MD PhD, Olga Salamero, MD, Jorge Sierra, MD, Goichi Yoshimoto, MD PhD, Kamel Laribi, MD, Janusz Halka, MD, Pau Montesinos, MD PhD, Shufang Liu, Elizabeth Shima Rich, MD PhD, Erkut Bahceci, MD

Blood (2018) 132 (Supplement 1): 2736.

https://doi.org/10.1182/blood-2018-99-110976

Published: 2018

Journal Articles

Androgen Therapy for Lower-Risk Myelodysplastic Syndrome

Eun-Ji Choi, MD, Je-Hwan Lee, MD PhD, Han-Seung Park, MD, Jung-Hee Lee, MD PhD, Miee Seol, Young-Shin Lee, Young-Ah Kang, Mijin Jeon, Ji Min Woo, Kyoo Hyung Lee, MD PhD

Blood (2018) 132 (Supplement 1): 1823.

https://doi.org/10.1182/blood-2018-99-115931

Published: 2018

Journal Articles

Intravenous Busulfan-Based Conditioning Regimens in Allogeneic Hematopoietic Cell Transplantation for Patients with Acute Lymphoblastic Leukemia

Sun-Hye Ko, MD PhD, Jung-Hee Lee, MD PhD, Han-Seung Park, MD, Je-Hwan Lee, MD PhD, Eun-ji Choi, MD, Miee Seol, Young-Shin Lee, RN, Young-Ah Kang, Mijin Jeon, Kyoo Hyung Lee, MD PhD

Blood (2017) 130 (Supplement 1): 3214.

https://doi.org/10.1182/blood.V130.Suppl_1.3214.3214

Published: 2017

Journal Articles

Fludarabine/Melphalan 100 Conditioning Therapy Followed By Allogeneic Hematopoietic Cell Transplantation for Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis

Han-Seung Park, MD, Jung-Hee Lee, MD PhD, Je-Hwan Lee, MD PhD, Eunji Choi, MD, Sun-Hye Ko, MD PhD, Miee Seol, Young-Shin Lee, Young-Ah Kang, Mijin Jeon, Kyoo Hyung Lee, MD PhD

Blood (2017) 130 (Supplement 1): 2033.

https://doi.org/10.1182/blood.V130.Suppl_1.2033.2033

Published: 2017

Journal Articles

Clinical Outcomes of Decitabine Treatment for Patients with Lower-Risk Myelodysplastic Syndrome By the International Prognostic Scoring System

Ki Sun Jung, Jun Ho Jang, MD PhD, Je-Hwan Lee, MD PhD

Blood (2017) 130 (Supplement 1): 1697.

https://doi.org/10.1182/blood.V130.Suppl_1.1697.1697

Published: 2017

Journal Articles

Inhibition of DNA Methyltransferases By Volasertib in HMA Resistant Cell Lines

Sun-Hye Ko, MD PhD, Eun-Hye Hur, PhD, Bon-Kwan Goo, Juhyun Moon, Eun-ji Choi, MD, Han-Seung Park, MD, Kyoo Hyung Lee, MD PhD, Jung-Hee Lee, MD PhD, Je-Hwan Lee, MD PhD

Blood (2017) 130 (Supplement 1): 4991.

https://doi.org/10.1182/blood.V130.Suppl_1.4991.4991

Published: 2017

Journal Articles

Prognostic Factors and Response to the Hypomethylating Agents in Hypocellular Myelodysplastic Syndromes: A Retrospective Study from the Korean Society of Hematology AML/MDS Working Party

Blood (2017) 130 (Supplement 1): 4257.

https://doi.org/10.1182/blood.V130.Suppl_1.4257.4257

Published: 2017

Journal Articles

Treatment Outcomes and Prognostic Factors of Patients with Relapsed Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Yunsuk Choi, MD PhD, Jung-Hee Lee, MD PhD, Kyoo-Hyung Lee, MD PhD, Han-Seung Park, MD, Eunji Choi, MD, Sun-Hye Ko, MD PhD, Miee Seol, R.N., Young-Shin Lee, MS, Young-Ah Kang, MS, Mijin Jeon, R.N., Je-Hwan Lee, MD PhD

Blood (2016) 128 (22): 4004.

https://doi.org/10.1182/blood.V128.22.4004.4004

Published: 2016

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Lymphoma: Baseline and Post-Transplant Prognostic Factors

Sun-Hye Ko, MD PhD, Jung-Hee Lee, MD PhD, Je-Hwan Lee, MD PhD, Han-Seung Park, MD, Eun-Ji Choi, MD, Young-Shin Lee, MS, Young-Ah Kang, MS, Kyoo-Hyung Lee, MD PhD

Blood (2016) 128 (22): 5858.

https://doi.org/10.1182/blood.V128.22.5858.5858

Published: 2016

Journal Articles

Killer Cell Immunoglobulin-like Receptor Ligand Matching Determines the Post-Transplant High Risk Groups Among Patients with Permissive HLA Mismatch in Unrelated Donor Hematopoietic Cell Transplantation

Yoo Jin Lee, MD, Joon Ho Moon, MD, PhD, In Hee Lee, MD, Jae-Ho Yoon, Byung-Sik Cho, Jae-Sook Ahn, MD PhD, Hyeoung Joon Kim, MD PhD, Silvia Park, Jun Ho Jang, MD PhD, Chul Won Jung, MD PhD, Hyunsung Park, MD, June-Won Cheong, MD, Je-Hwan Lee, MD PhD, Sang Kyun Sohn, MD, PhD, Hee-Je Kim

Blood (2016) 128 (22): 4566.

https://doi.org/10.1182/blood.V128.22.4566.4566

Published: 2016

Journal Articles

Role of Daunorubicin Dose Intensification for Induction Therapy in Acute Myeloid Leukemia Patients with FLT3-ITD Mutants

Eun-Ji Choi, MD, Je-Hwan Lee, MD PhD, Jung-Hee Lee, MD PhD, Han-Seung Park, MD, Sun-Hye Ko, MD PhD, Miee Seol, MS, Ji Min Woo, Kyoo-Hyung Lee, MD PhD

Blood (2016) 128 (22): 4033.

https://doi.org/10.1182/blood.V128.22.4033.4033

Published: 2016

Journal Articles

Identification of Novel Fusion Genes and Differentially Expressed Genes in Acute Leukemia through Transcriptome Analysis

Dong-Hyun Lee, MD, Young-Uk Cho, MD PhD, Seongsoo Jang, MD PhD, Chan-Jeoung Park, MD PhD, Mi Hyun Bae, MD PhD, Dae-Young Kim, MD PhD, Jung-Hee Lee, MD PhD, Je-Hwan Lee, MD PhD, Kyoo-Hyung Lee, MD PhD, Jong Jin Seo, MD PhD, Eul-Ju Seo, MD PhD

Blood (2015) 126 (23): 1220.

https://doi.org/10.1182/blood.V126.23.1220.1220

Published: 2015

Journal Articles

A Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in the Induction Chemotherapy for Acute Myeloid Leukemia

Je-Hwan Lee, MD PhD, Hawk Kim, MD PhD, Young-Don Joo, MD, Won Sik Lee, Sung Hwa Bae, MD, Dae Young Zang, Jihyun Kwon, MD, Min Kyoung Kim, Junglim Lee, MD, Gyeong Won Lee, Jung-Hee Lee, MD PhD, Yunsuk Choi, MD PhD, Dae-Young Kim, MD PhD, Sung-Nam Lim, MD, Sang-Min Lee, Hun-Mo Ryoo, MD, Hyo Jung Kim, Myung Soo Hyun, Kyoo-Hyung Lee, MD PhD

Blood (2015) 126 (23): 2535.

https://doi.org/10.1182/blood.V126.23.2535.2535

Published: 2015

Journal Articles

Ethnic Difference in Genomic Profiles of Chronic Lymphocytic Leukemia in Korea: Targeted Exome Sequencing and Molecular Cytogenetics

Jung-Ah Kim, MD, Byungjin Hwang, Si Nae Park, Sunghoon Huh, Kyongok Im, B.S, Seon Young Kim, MD PhD, Joo Ryung Huh, MD PhD, Eul-Ju Seo, MD PhD, Je-Hwan Lee, MD PhD, Sunghoon Kwon, PhD, Sung-Soo Yoon, MDPhD, Duhee Bang, PhD, Dong Soon Lee

Blood (2015) 126 (23): 1726.

https://doi.org/10.1182/blood.V126.23.1726.1726

Published: 2015

Journal Articles

Lenalidomide As a Second-Line Therapy after Failure of Hypomethylating Agents in Patients with Myelodysplastic Syndrome

Hawk Kim, MD PhD, Je-Hwan Lee, MD PhD, Won-Sik Lee, MD, Inho Kim, Joon Ho Moon, MD, PhD, Chul Won Choi, MD PhD, Ho Sup Lee, MD PhD, Jinny Park, Ho-Jin Shin, Kyoung Ha Kim, MD, Su-Hee Cho, MD PhD, Sung-Yong Kim, MD, Yoo-Jin Kim

Blood (2015) 126 (23): 1687.

https://doi.org/10.1182/blood.V126.23.1687.1687

Published: 2015

Journal Articles

Frequency, Characteristics and Prognostic Significance of RUNX1 mutations in Patients with Acute Myeloid Leukemia, Not Otherwise Specified

Mi-Hyun Bae, MD PhD, Young-Uk Cho, MD PhD, Bohyun Kim, Dong Hyun Lee, Seongsoo Jang, MD PhD, Eul-Ju Seo, MD PhD, Chan-Jeoung Park, MD PhD, Dae-Young Kim, MD PhD, Jung-Hee Lee, MD PhD, Je-Hwan Lee, MD PhD, Kyoo-Hyung Lee, MD PhD, Yoon Hwan Chang, In-Suk Kim

Blood (2015) 126 (23): 3860.

https://doi.org/10.1182/blood.V126.23.3860.3860

Published: 2015

NARROW

DDX41 mutation in Patients with Idiopathic Cytopenia of Undetermined Significance, Myelodysplastic Syndrome, and Acute Myeloid Leukemia

Mutational Characteristics and Changing Pattern from Idiopathic Cytopenia of Undetermined Significance to High-Risk Myelodysplastic Syndrome Stratified By IPSS-R

Clinical Implications of Copy Number Variant Detection from Panel-Based Next-Generation Sequencing Data in Myelodysplastic Syndrome

Decitabine Versus Intensive Chemotherapy for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Multicenter, Open-Label, 3-Arm Study of Gilteritinib, Gilteritinib Plus Azacitidine, or Azacitidine Alone in Newly Diagnosed FLT 3 Mutated ( FLT3 mut+ ) Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Induction Chemotherapy: Findings from the Safety Cohort

Androgen Therapy for Lower-Risk Myelodysplastic Syndrome

Intravenous Busulfan-Based Conditioning Regimens in Allogeneic Hematopoietic Cell Transplantation for Patients with Acute Lymphoblastic Leukemia

Fludarabine/Melphalan 100 Conditioning Therapy Followed By Allogeneic Hematopoietic Cell Transplantation for Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis

Clinical Outcomes of Decitabine Treatment for Patients with Lower-Risk Myelodysplastic Syndrome By the International Prognostic Scoring System

Inhibition of DNA Methyltransferases By Volasertib in HMA Resistant Cell Lines

Prognostic Factors and Response to the Hypomethylating Agents in Hypocellular Myelodysplastic Syndromes: A Retrospective Study from the Korean Society of Hematology AML/MDS Working Party

Treatment Outcomes and Prognostic Factors of Patients with Relapsed Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic Hematopoietic Cell Transplantation for Lymphoma: Baseline and Post-Transplant Prognostic Factors

Killer Cell Immunoglobulin-like Receptor Ligand Matching Determines the Post-Transplant High Risk Groups Among Patients with Permissive HLA Mismatch in Unrelated Donor Hematopoietic Cell Transplantation

Role of Daunorubicin Dose Intensification for Induction Therapy in Acute Myeloid Leukemia Patients with FLT3-ITD Mutants

Identification of Novel Fusion Genes and Differentially Expressed Genes in Acute Leukemia through Transcriptome Analysis

A Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in the Induction Chemotherapy for Acute Myeloid Leukemia

Ethnic Difference in Genomic Profiles of Chronic Lymphocytic Leukemia in Korea: Targeted Exome Sequencing and Molecular Cytogenetics

Lenalidomide As a Second-Line Therapy after Failure of Hypomethylating Agents in Patients with Myelodysplastic Syndrome

Frequency, Characteristics and Prognostic Significance of RUNX1 mutations in Patients with Acute Myeloid Leukemia, Not Otherwise Specified

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only